NOVO.B.DK

261.9

+0.23%↑

GMAB.DK

1,685

-1.32%↓

HLUNB.DK

42.92

-1.74%↓

ZEAL.DK

311.5

+3.35%↑

AMBUB.DK

64.65

-0.31%↓

NOVO.B.DK

261.9

+0.23%↑

GMAB.DK

1,685

-1.32%↓

HLUNB.DK

42.92

-1.74%↓

ZEAL.DK

311.5

+3.35%↑

AMBUB.DK

64.65

-0.31%↓

NOVO.B.DK

261.9

+0.23%↑

GMAB.DK

1,685

-1.32%↓

HLUNB.DK

42.92

-1.74%↓

ZEAL.DK

311.5

+3.35%↑

AMBUB.DK

64.65

-0.31%↓

NOVO.B.DK

261.9

+0.23%↑

GMAB.DK

1,685

-1.32%↓

HLUNB.DK

42.92

-1.74%↓

ZEAL.DK

311.5

+3.35%↑

AMBUB.DK

64.65

-0.31%↓

NOVO.B.DK

261.9

+0.23%↑

GMAB.DK

1,685

-1.32%↓

HLUNB.DK

42.92

-1.74%↓

ZEAL.DK

311.5

+3.35%↑

AMBUB.DK

64.65

-0.31%↓

Search

Coloplast A-S (Class B)

Deschisă

403.3 -1.54

Rezumat

Modificarea prețului

24h

Curent

Minim

400.4

Maxim

408.4

Indicatori cheie

By Trading Economics

Venit

522M

1.4B

Vânzări

83M

7B

P/E

Medie Sector

24.492

60.328

EPS

6.32

Randament dividend

5.28

Marjă de profit

19.835

Angajați

16,983

EBITDA

309M

2.3B

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+11.86% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

5.28%

2.24%

Următoarele câștiguri

12 mai 2026

Data viitoare de dividende

20 mai 2026

Următoarea dată ex-dividende

18 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-21B

98B

Deschiderea anterioară

404.84

Închiderea anterioară

403.3

Coloplast A-S (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

27 apr. 2026, 23:15 UTC

Evenimente importante

U.K. Consumers Pay Less But Full Impact of Mideast War to Be Seen

27 apr. 2026, 23:08 UTC

Câștiguri
Principalele dinamici ale pieței

LendingClub Shares Gain on 1Q Profit, Revenue Beat

27 apr. 2026, 23:58 UTC

Câștiguri

Samsung SDI 1Q Net Profit Beat FactSet-Compiled Consensus

27 apr. 2026, 23:58 UTC

Câștiguri

Samsung SDI 1Q Net KRW56.10B Vs. Loss KRW216.00B >006400.SE

27 apr. 2026, 23:56 UTC

Câștiguri

Samsung SDI 1Q Oper Loss KRW155.60B Vs. Loss KRW434.10B >006400.SE

27 apr. 2026, 23:56 UTC

Câștiguri

Samsung SDI 1Q Rev KRW3.576T Vs. KRW3.177T >006400.SE

27 apr. 2026, 23:48 UTC

Market Talk

Nikkei May Remain Rangebound Amid Uncertainty Over Iran Conflict -- Market Talk

27 apr. 2026, 23:42 UTC

Market Talk

Australian Consumer Confidence Making a Slow Come Back -- Market Talk

27 apr. 2026, 23:34 UTC

Market Talk
Evenimente importante

Gold Edges Higher as Investors Assess Iran's Proposal to U.S. -- Market Talk

27 apr. 2026, 23:30 UTC

Market Talk

Australia's NDIS Could Lose 'Social Licence' If Not Reined In -- Market Talk

27 apr. 2026, 23:08 UTC

Market Talk

Polymetals's Revenue Outlook 'Extraordinary' for a Small-Cap Stock -- Market Talk

27 apr. 2026, 23:02 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

27 apr. 2026, 23:02 UTC

Market Talk

Warsh Will Probably Lean a Bit More Dovish Than Powell -- Market Talk

27 apr. 2026, 22:42 UTC

Market Talk

BOJ Expected to Keep Rates On Hold; Guidance to Skew Hawkish -- Market Talk

27 apr. 2026, 22:10 UTC

Câștiguri

Haier Smart Home: Results Also Weighed by Weak Demand in China-U.S. Markets >600690.SH

27 apr. 2026, 22:09 UTC

Câștiguri

Haier Smart Home: Increase in Tariff Costs, Extreme Weather Conditions Hurt Results >600690.SH

27 apr. 2026, 22:09 UTC

Câștiguri

Haier Smart Home 1Q Net CNY4.65B Vs. Net CNY5.49B >600690.SH

27 apr. 2026, 22:09 UTC

Câștiguri

Haier Smart Home 1Q Rev CNY73.69B Vs. CNY79.12B >600690.SH

27 apr. 2026, 21:56 UTC

Câștiguri

Tsingtao Brewery: Cost Controls Among Factors Supporting Results >0168.HK

27 apr. 2026, 21:55 UTC

Câștiguri

Tsingtao Brewery 1Q Net CNY1.80B Vs. Net CNY1.71B >0168.HK

27 apr. 2026, 21:55 UTC

Câștiguri

Tsingtao Brewery 1Q Rev CNY10.29B Vs. CNY10.45B >0168.HK

27 apr. 2026, 21:44 UTC

Câștiguri

Tianqi Lithium: Higher Demand for Products From EV Sector Also Boosted Financial Performance >002466.SZ

27 apr. 2026, 21:43 UTC

Câștiguri

Tianqi Lithium: Increase in Average Selling Prices of Major Lithium Products Supported Results >002466.SZ

27 apr. 2026, 21:41 UTC

Câștiguri

Tianqi Lithium 1Q Rev CNY5.13B Vs. CNY2.58B >002466.SZ

27 apr. 2026, 21:41 UTC

Câștiguri

Tianqi Lithium 1Q Net CNY1.88B Vs. Net CNY104.27M >002466.SZ

27 apr. 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

27 apr. 2026, 20:50 UTC

Market Talk
Evenimente importante

Basic Materials Roundup: Market Talk

27 apr. 2026, 20:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Financial Services Roundup: Market Talk

27 apr. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

27 apr. 2026, 20:39 UTC

Câștiguri

Nucor: Operating Segments Earnings Growth Driven by Trade Policies That Continue to Reduce Flood of Unfairly Traded Imports Into U.S. >NUE

Comparație

Modificare preț

Coloplast A-S (Class B) Așteptări

Obiectiv de preț

By TipRanks

11.86% sus

Prognoză pe 12 luni

Medie 901.38 DKK  11.86%

Maxim 1,056 DKK

Minim 720 DKK

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruColoplast A-S (Class B) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

8 ratings

2

Cumpărare

4

Păstrare

2

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat